Fund is a financial instrument, not an implementing
Fund will make available and leverage additional financial
resources to combat HIV AIDS, tuberculosis and malaria.
Fund will base its work on programs that reflect national
ownership and respect country-led formulation and
Fund will seek to operate in a balanced manner in
terms of different regions, diseases and interventions.
Fund will pursue an integrated and balanced approach
covering prevention, treatment, and care and support in
dealing with the three diseases.
Fund will evaluate proposals through independent review
processes based on the most appropriate scientific
and technical standards that take into account local realities
Fund will seek to establish a simplified, rapid, innovative
process with efficient and effective disbursement
mechanisms, minimizing transaction costs and operating
in a transparent and accountable manner based on clearly
defined responsibilities. The Fund should make use of
existing international mechanisms and health plans.
on best practices by funding interventions that work
and can be scaled up to reach people affected by HIV AIDS,
tuberculosis, and malaria.
and reflect high-level, sustained political involvement
and commitment in making allocations of its resources.
the substantial scaling up and increased coverage of proven
and effective interventions, which strengthen systems
for working: within the health sector; across government
departments; and with communities.
on, complement, and co-ordinate with existing regional
and national programs (including governments, public/private
partnerships, NGOs, and civil society initiatives) in
support of national policies, priorities and partnerships,
including Poverty Reduction Strategies and sector-wide
on performance by linking resources to the achievement
of clear, measurable and sustainable results.
on the creation, development and expansion of government/private/NGO
the participation of communities and people, particularly
those infected and directly affected by the three diseases,
in the development of proposals.
consistent with international law and agreements,
respect intellectual property rights, such as Trade-Related
Aspects of Intellectual Property Rights (TRIPS), and encourage
efforts to make quality drugs and products available at
the lowest possible prices for those in need.
due priority to the most affected countries and communities,
and to those countries most at risk.
to eliminate stigmatisation of and discrimination
against those infected and affected by HIV AIDS, especially
for women, children and vulnerable groups.